DEA Proposes Quota Rule Revision for Schedule I/II Substances and List I Chemicals
DEA proposed reorganizing quota rules for schedule I and II substances and list I chemicals, including ephedrine, pseudoephedrine, and phenylpropanolamine. Public comments are due in 60 days, by July 20, 2026.
Key Facts
- DEA proposed revising regulations for manufacturing and procurement quotas.
- The proposal covers schedule I and II controlled substances and list I chemicals.
- The named list I chemicals include ephedrine, pseudoephedrine, and phenylpropanolamine.
- The agency said the revision is intended to improve clarity and consistency in quota regulations.
- The comment period ends in 60 days, on July 20, 2026.
What Happened
The Drug Enforcement Administration proposed revisions to its regulations governing manufacturing and procurement quotas for schedule I and II controlled substances and certain list I chemicals. The source said the chemicals specifically named in the proposal are ephedrine, pseudoephedrine, and phenylpropanolamine.
The stated purpose is to restructure the quota regulations for more clarity and consistency and to clarify which use-specific subcategories should be used for quota applications.
Why It Matters
For manufacturers and downstream buyers that touch DEA-controlled materials, quota rules affect planning, purchasing, and production timing. A regulatory rewrite can change how applications are prepared even when the underlying controlled status of a material does not change.
For compliance teams and EHS leads, the practical issue is whether internal quota workflows, documentation templates, and approval gates still align with the revised structure the DEA is proposing.
Key Details
The proposal applies to DEA-registered manufacturers and covers both manufacturing and procurement quota management. The source said the revision is aimed at better organizing the existing framework, rather than introducing a different category of materials.
- Scope: schedule I and II controlled substances plus list I chemicals.
- Named list I chemicals: ephedrine, pseudoephedrine, phenylpropanolamine.
- Objective: more clarity and consistency in quota regulations.
- Application focus: use-specific subcategories for quota requests.
- Comment deadline: 60 days from publication, ending July 20, 2026.
The Federal Register page also notes that the document is part of the daily Federal Register prototype and that readers should verify legal research against the official edition.
What To Watch Next
Buyers and operators that rely on quota-managed inputs should watch for any final rule language that changes how applications are categorized or documented. Even a technical reorganization can affect internal compliance checklists and supply planning.
Stakeholders may also want to review the proposal and submit comments before the July 20, 2026 deadline if the revised structure could affect their quota filings or procurement processes.
Alliance's Take
Customers that buy, store, or process quota-managed materials should compare current approval workflows against the DEA’s proposed subcategory structure. The main operational risk is misaligned paperwork, not a change in material demand.
Compliance teams should use the comment window to flag any filing categories that could disrupt procurement timing, supplier coordination, or inventory planning if the rule is finalized as proposed.
Related Products
Frequently Asked Questions
Which materials are covered by the proposal?
The proposal covers schedule I and II controlled substances and the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine.
What is the DEA trying to change?
The DEA said it wants to restructure the quota regulations for more clarity and consistency and clarify which use-specific subcategories should be used.
When do comments close?
The comment period ends in 60 days, on July 20, 2026.
Sources
- Revision of Applications for Manufacturing and Procurement Quotas — Federal Register (2026)
- Original full text XML
